Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.

LRMR

Larimar Therapeutics (LRMR)

Larimar Therapeutics Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:LRMR
FechaHoraFuenteTítuloSímboloCompañía
10/06/202405:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LRMRLarimar Therapeutics Inc
31/05/202415:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
27/05/202423:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:LRMRLarimar Therapeutics Inc
09/05/202415:50Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:LRMRLarimar Therapeutics Inc
14/02/202419:57Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:LRMRLarimar Therapeutics Inc
14/02/202416:08Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LRMRLarimar Therapeutics Inc
14/11/202312:51Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LRMRLarimar Therapeutics Inc
25/07/202312:06Dow Jones NewsLarimar Therapeutics Shares Rise 10% After FDA Clears CTI-1601 TrialNASDAQ:LRMRLarimar Therapeutics Inc
18/07/202315:13Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:LRMRLarimar Therapeutics Inc
01/06/202315:07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LRMRLarimar Therapeutics Inc
18/05/202313:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LRMRLarimar Therapeutics Inc
11/04/202315:06Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:LRMRLarimar Therapeutics Inc
17/03/202305:01Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:LRMRLarimar Therapeutics Inc
14/03/202315:04Edgar (US Regulatory)Annual Report (10-k)NASDAQ:LRMRLarimar Therapeutics Inc
13/02/202311:05Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:LRMRLarimar Therapeutics Inc
09/02/202315:59Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:LRMRLarimar Therapeutics Inc
07/12/202223:25TipRanksJMP Securities Sticks to Their Buy Rating for Larimar Therapeutics (LRMR)NASDAQ:LRMRLarimar Therapeutics Inc
22/11/202205:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:LRMRLarimar Therapeutics Inc
10/11/202216:17Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:LRMRLarimar Therapeutics Inc
10/11/202208:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LRMRLarimar Therapeutics Inc
21/09/202205:42TipRanksLarimar Therapeutics (NASDAQ:LRMR) Stock Soars on Notable Insider BuyingNASDAQ:LRMRLarimar Therapeutics Inc
19/09/202211:20TipRanksLarimar Therapeutics (NASDAQ:LRMR) Gains after JMP Securities Sees ~400% UpsideNASDAQ:LRMRLarimar Therapeutics Inc
18/09/202223:25TipRanksLarimar Therapeutics (LRMR) Receives a Buy from JMP SecuritiesNASDAQ:LRMRLarimar Therapeutics Inc
14/09/202206:59Dow Jones NewsLarimar Therapeutics: FDA Cleared New Cohort of CTI-1601 to Treat Friedreich's AtaxiaNASDAQ:LRMRLarimar Therapeutics Inc
11/08/202223:25TipRanksJMP Securities Remains a Buy on Larimar Therapeutics (LRMR)NASDAQ:LRMRLarimar Therapeutics Inc
11/08/202216:39Dow Jones NewsLarimar Therapeutics Shares Soar 54% After Hours On CTI-1601 UpdateNASDAQ:LRMRLarimar Therapeutics Inc
15/05/202209:18TipRanksLifeSci Capital Keeps Their Hold Rating on Larimar Therapeutics (LRMR)NASDAQ:LRMRLarimar Therapeutics Inc
25/03/202213:35TipRanksJMP Securities Thinks Larimar Therapeutics’ Stock is Going to RecoverNASDAQ:LRMRLarimar Therapeutics Inc
18/02/202215:34Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:LRMRLarimar Therapeutics Inc
15/02/202210:04Dow Jones NewsLarimar Therapeutics Shares Plumb New Lows as FDA Extends HoldNASDAQ:LRMRLarimar Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:LRMR

Su Consulta Reciente

Delayed Upgrade Clock